Peptides of pineal gland and thymus prolong human life
Khavinson V.Kh., Morozov V.G.
St. Petersburg Institute of Bioregulation and Gerontology
Neuro Endocrinology Letters 24(3-4): 233-240
Abstract
The authors followed 266 older adults for 6-8 years; Thymalin and/or Epithalamin (injectable peptide extracts) were given during the first 2-3 years. They report lower acute respiratory illness and lower mortality versus controls: 2.0-2.1-fold in the Thymalin group, 1.6-1.8-fold with Epithalamin and 2.5-fold with both. A group treated annually for 6 years had 4.1-fold lower mortality. This was not a placebo-controlled randomized trial. Summary based on the PubMed abstract (PMID 14523363).
What the study did
The authors followed 266 older adults for 6-8 years; Thymalin and/or Epithalamin (injectable peptide extracts) were given during the first 2-3 years. They report lower acute respiratory illness and lower mortality versus controls: 2.0-2.1-fold in the Thymalin group, 1.6-1.8-fold with Epithalamin and 2.5-fold with both. A group treated annually for 6 years had 4.1-fold lower mortality. This was not a placebo-controlled randomized trial.
Reading it honestly
This summary is based on the PubMed abstract (PMID 14523363). It describes research on the named preparation, not on any capsule product sold today, and it is not a claim that any product treats or prevents a disease.
Looking for oral pineal and thymus bioregulators?
Neither Epithalamin nor Thymalin (both injectable extracts) is sold by Vita-Stream, our affiliate partner. The closest oral products it carries are Endoluten (A-8), a pineal-gland bioregulator, and Thymusol, Vita's US-made thymus bioregulator. This study tested neither, so treat them as related products, not the ones studied.
Use code KymataLabs at checkout
Affiliate links: The Bioregulator Atlas earns a commission if you buy through these Vita-Stream links, at no extra cost to you. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Talk to a healthcare professional before use.
Study Limitations
- •Summary based on the PubMed abstract only
- •Single research group; independent replication is limited
- •Results concern the studied preparation, not any capsule product
Key Findings
- ✓Lower reported mortality in treated groups
- ✓Lower reported respiratory illness incidence
- ✓Single research group; no independent replication
Mechanism of Action
Not studied; the authors describe normalization of several body systems.